Skip to content
   

Fourth quarter and full year
results 2008

Announced Thursday, 29 January 2009

View details of the event

Our International website, www.astrazeneca.com, will be available shortly.

Updated Currency Guidance 2009

 View 2009 currency guidance

Contact Investor Relations

UK: +44 (0)20 7304 5000
US: +1 (302) 886 3000
Sweden: +46 (0)8 553 260 00

Contact Press Office

UK
Chris Sampson
+44 (0)207 304 5130
Sarah Lindgreen
+44 (0)207 304 5033
Neil McCrae 
+44 (0)207 304 5045

Sweden
Anne-Charlotte Knutsson
+46 (0)8 553 213 75
Anna Carbin-Åhlund 
+46 (0)8 553 269 39

US
Tony Jewell 
+1 302 885 4594
Earl Whipple 
+1 302 885 8197

Latest news 
> 29 January 2009 : AstraZeneca PLC Fourth Quarter and Full Year Results 2008
> 24 December 2008 : AstraZeneca Receives FDA Complete Response Letter on Seroquel XR for Major Depressive Disorder
> 19 December 2008 : AstraZeneca and MAP Pharmaceuticals Announce Worldwide Collaboration To Develop and Commercialise Unit Dose Budesonide
> 11 December 2008 : AstraZeneca Responds to FDA Joint Advisory Committees’ Recommendation on Symbicort
> 8 December 2008 : AstraZeneca and Bristol-Myers Squibb Announce Expansion of Worldwide Collaboration to Develop and Commercialise Dapagliflozin in Japan
> 8 December 2008 : AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
AstraZeneca websites
Share price
>
>
>